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In Brief Pilaz et al. use live imaging and genetic and pharmacological approaches to demonstrate a causal relationship between prolonged mitosis of neural progenitors and fate specification in the developing brain. Their study has implications for understanding neurodevelopmental disorders such as microcephaly.
INTRODUCTION
During neurogenesis of the developing dorsal telencephalon, radial glial progenitors (RGCs) divide adjacent to the ventricle to generate new neurons and progenitors ( Figure 1A ) (Malatesta et al., 2000; Noctor et al., 2001) . RGCs undergo symmetric proliferative divisions to self-renew and asymmetric neurogenic divisions to generate a new RGC and either a neuron or an intermediate progenitor (IP) (Franco and Mü ller, 2013) . IPs undergo one to two self-renewal divisions before producing neurons (Kowalczyk et al., 2009 ). The precise balance of RGC divisions and resulting progeny ultimately influences the size and function of the mature neocortex. This is exemplified in human and mouse microcephaly models in which reduced brain size is associated with altered neurogenesis, including common phenotypes of depleted progenitors, precocious neurons, and apoptosis (Asami et al., 2011; Gruber et al., 2011; Lizarraga et al., 2010; Marthiens et al., 2013; McIntyre et al., 2012; Silver et al., 2010; Xie et al., 2013; Yingling et al., 2008) . As most human microcephaly-associated genes identified to date encode mitotic regulators, aberrant progenitor division has been invoked in the etiology of this disease (Hu et al., 2014 ). Yet how altered progenitor mitosis impacts cell fate changes associated with microcephaly remains unclear.
Several aspects of progenitor mitosis have been implicated in neocortical fate specification. Spindle orientation is strongly linked to neuron production and survival, and generation of basally dividing cells (Asami et al., 2011; Konno et al., 2008; LaMonica et al., 2013; Lizarraga et al., 2010; Mora-Bermú dez et al., 2014; Xie et al., 2013; Yingling et al., 2008) . Spindle-size asymmetry is associated with asymmetric divisions (Delaunay et al., 2014) . Mitotic progression defects can trigger mitotic catastrophe, in which progenitors die prior to division (Chen et al., 2014; Novorol et al., 2013) or massive apoptosis in mice with altered centrosome number (Insolera et al., 2014; Marthiens et al., 2013) . However, the specific impact of prolonged mitosis on fate specification is unclear. An important unanswered question is whether there is a direct causal relationship between prolonged progenitor mitosis and pathogenic production of neurons and apoptotic progeny in the developing brain ( Figure 1B ).
Here we address this critical issue by demonstrating that prolonged M phase of RGCs directly alters progenitor and neuronal cell fates in the developing brain. First we employ live imaging of Magoh +/À brain slices and primary progenitors. This mutant exhibits microcephaly and neurogenesis phenotypes, which are attributable in part to altered levels of the microtubule protein LIS1 (Silver et al., 2010) . Compared with non-delayed Magoh +/À RGCs, we find that mitotically delayed Magoh +/À RGCs produce significantly fewer RGCs and more apoptotic progeny. Independently, we employ a reversible pharmacological paradigm using two distinct drugs to prolong mitosis both ex vivo and in vitro. We show that prolonged RGC mitosis alone recapitulates altered differentiation and apoptotic fates, with only the latter occurring via a p53-dependent mechanism. Our results indicate prolonged mitosis of RGCs causes preferential generation of progeny with two mutually independent fates, differentiation and apoptosis.
RESULTS
In Vivo Cell-Cycle Analysis Reveals that MagohDeficient Radial Glia Exhibit a Significant Mitotic Delay We previously discovered that mice haploinsufficient for Magoh exhibit microcephaly and severe neurogenesis defects, including depleted IPs, ectopic neurons, and apoptosis (McMahon et al., 2014; Silver et al., 2010) . Although Magoh is required for proper mitosis of cultured cells and melanoblasts (Silver et al., 2010 (Silver et al., , 2013 , it remains unclear whether it regulates mitosis duration of neural progenitors and whether this is relevant for altered cell fate during corticogenesis. Moreover, G1-and S-phase durations are linked to RGC proliferative behavior (Arai et al., 2011; Lange et al., 2009; Pilaz et al., 2009 ), but the role of M phase in RGC function is poorly understood. We assessed population level cell cycle using a cumulative BrdU/EdU labeling paradigm at E13.5 (Quinn et al., 2007) , when neurogenesis is markedly disrupted in Magoh +/À (Silver et al., 2010) ( Figures 1C-1G ). Relative mitotic index was calculated as the fraction of mitotic cells among Ki67+ cycling progenitors ( Figures 1H-1J ). Although total cell cycle (Tc) and S phase (Ts) were similar between control and Magoh +/À RGCs ( Figure 1G ), mitotic index was increased in Magoh +/À RGCs ( Figure 1J , p < 0.05). These results suggest that within the normal Tc-Ts fraction, RGC mitosis is lengthened. Using g-TUBULIN and Hoechst staining to mark centrosomes, we quantified a significantly higher fraction of Magoh +/À RGCs in prometaphase (PM) and metaphase (M) (Figures 1K-1O ). (K-N) E13.5 sections from control (K and L) and Magoh +/À (M and N) cortices stained for g-TUBULIN (red) and Hoechst (green) (dotted circle, mitotic RGC).
(O) Proportion of RGCs in each mitosis phase for indicated genotypes. ns, not significant; * and #, p < 0.05; *, t test; and #, chi-square analysis. Scale bars represent (C-F) 50 mm, (H and I) 25 mm, and (K-N) 10 mm. Error bars represent SD.
mitotic duration (Figures S1A-S1C; Movie S5). Overall, these data indicate Magoh +/À RGCs exhibit significant mitotic delay.
In Magoh +/À brains, mitotic delay is concomitant with increased neuronal apoptosis (Silver et al., 2010 2C ; Movies S1 and S2) (Pilaz and Silver, 2014) . Control RGCs completed mitosis on average in 79.9 min ( Figure S2A ), similar to previous measurements of mitosis duration (Haydar et al., 2003) . In contrast, Magoh +/À RGCs were markedly delayed in mitosis, averaging 94.7 min. RGC mitotic delay was also evident in Syto11-stained Magoh +/À brains ( Figure S2B ; Movie S3 (Figure 2D) . Magoh +/À RGCs exhibited a broad range of PM+M durations, with 66% dividing normally (<60 min) and 34% significantly delayed (R60 min, p < 0.001) ( Figure 2E ). Among those Magoh +/À delayed progenitors, 62% eventually divided ( Figure S2E ). During the 5-hr imaging session, we never observed mitotic catastrophe, suggesting that most delayed Magoh +/À RGCs eventually divide.
Together these data indicate a significant fraction of Magoh
RGCs progress slower through PM+M. We sought to further define the cellular mechanism by which Magoh levels affect mitotic progression. Defective centrosome number and maturation are associated with microcephaly and mitosis defects (Gruber et al., 2011; Insolera et al., 2014; Marthiens et al., 2013) . However, Magoh-deficient RGCs showed normal centrosome distance and number as demonstrated by g-TUBULIN staining ( Figures 1K-1N (Skoufias et al., 2006) and NUMA (Gaglio et al., 1995) , both required for mitotic microtubules ( Figures S3B-S3J ). Of note, mutations in KIF11 cause human microcephaly (Ostergaard et al., 2012) . Together with the previous finding that Magoh controls microcephaly-associated LIS1 protein levels (Silver et al., 2010) , these analyses indicate altered microtubule regulation, rather than centrosome dysfunction, is associated with Magoh +/À mitotic defects ( Figure S3TT ).
We next assessed whether prometaphase delay was associated with aneuploidy ( Figures S4A-S4F ). Control and Magoh +/À E13.5 RGCs showed no evidence of aneuploidy, as evaluated by DNA FISH (Figures S4A-S4D ). This result was not due to death of aneuploid cells, as evidenced by normal ploidy in a p53 À/À background, which prevents apoptosis ( Figure S4E ). Thus, in contrast to some microcephaly models (Marthiens et al., 2013) , aneuploidy is not associated with Magoh +/À -delayed RGCs.
As spindle orientation is strongly implicated in neurogenesis and microcephaly phenotypes (Asami et al., 2011; Xie et al., 2013; Yingling et al., 2008) , it is possible that mitotic delay causes spindle mis-orientation, or alternatively, that these could be independent phenotypes. To distinguish between these scenarios, we analyzed spindle orientation and rotation in our 3D time-lapse imaging of E13.5 mitotic RGCs (Figures 2B and 2C ; Movies S1, S2, S3, and S4). Magoh +/À PM+M spindles underwent 1.6-fold more rotation than control ( Figures S4G-S4J ) (Haydar et al., 2003) . In control anaphase progenitors, most cleavage planes were oriented between 60 -90 , as previously reported (Konno et al., 2008; Xie et al., 2013) (Figures S4K and S4L ). In comparison, Magoh +/À anaphase progenitors exhibited a significantly broader range of cleavage plane orientations spanning from 0 -90 ( Figures S4L and S4M ). This corroborates previous analyses of fixed Magoh +/À E11.5 and E12.5 brains (Silver et al., 2010) . Importantly, we observed no significant correlation between prometaphase duration and altered spindle rotation or anaphase cleavage plane orientation ( Figures S4J and S4M Figure 3C ; Movie S6). In vivo, Magoh +/À apoptosis is accompanied by altered numbers of neurons and progenitors, prompting us to assess the fates of viable divisions. We defined proliferative divisions as production of two progenitors (RGCs and/or IPs, both DsRedÀ) and neurogenic divisions as generation of at least one neuron (DsRed+). In comparison to control, Magoh +/À E12.5 progenitors underwent significantly more neurogenic divisions ( Figure 3D ). Apoptosis and Dcx::DsRed expression were evident concurrently around 6 hr after division, making it difficult to disentangle these two fates. Altogether, these findings indicate that Magoh +/À progenitors exhibit prolonged mitosis, as well as altered proliferative, neurogenic, and apoptotic divisions. We refined our live-imaging analysis to specifically examine RGCs. Mutant mice were bred onto a Tbr2-EGFP background (Arnold et al., 2009 ). At E12.5, RGCs were identified as EGFPÀ (93% of dividing cells), and IPs were identified as EGFP+. We performed live-imaging clonal analysis as before with two exceptions: only RGC divisions were analyzed, and progeny were assessed by immunostaining for neurons (TUJ1 + ), RGCs (PAX6 + ), and Tbr2-EGFP for IPs (Figures 3E and 3F) . Consistent with all prior experiments described above, Magoh haploinsufficient RGCs displayed 1.8-fold longer mitoses relative to control ( Figure 3G ). All Magoh +/À RGCs produced significantly more apoptotic progeny than control RGCs, generating either one or two apoptotic progeny to equivalent degrees (Figures S5A and S5B) . Additionally, all Magoh +/À RGCs underwent more neurogenic divisions than control ( Figure S5C ). Thus, two independent reporters (Dcx::DsRed and TUJ1 staining) reveal that Magoh +/À progenitors/RGCs exhibit increased neuron-generating divisions.
Generation of Aberrant Progeny in Mitotically Delayed but Not Normally Dividing Magoh +/-Radial Glia
These findings established that total progenitor and RGC populations exhibit mitotic delay concomitant with altered progeny cell fates. We hypothesized that among Magoh +/À RGCs, those delayed in mitosis preferentially generate neurons and apoptotic progeny. To assess this, we examined progeny derived from either delayed or non-delayed RGCs. Virtually all control RGCs (98%) completed mitosis within 40 min ( Figures  3H and S5D ). Therefore, normal and delayed mitosis was classified as <40 or >40 min, respectively. In contrast, only 62% of Magoh +/À RGCs completed mitosis normally, and 38% were delayed ( Figure 3H ). This distribution of mitotic delay is remarkably similar to that observed in Magoh +/À slices (compare Figures 2E and 3H) . We then assessed production of apoptotic progeny in delayed versus non-delayed Magoh +/À RGCs. Both control and non-delayed Magoh +/À RGCs produced primarily viable progeny, with no significant difference between genotypes ( Figure 3I ). In sharp contrast, delayed Magoh +/À RGCs produced significantly more apoptotic progeny than non-delayed mutant RGCs ( Figure 3I , p < 0.01). Strikingly, as mitotic duration increased up to 80 min or greater, there was a significant correlative increase in production of apoptotic cells ( Figure 3J , p < 0.001). Consistent with this, apoptotic divisions were on average significantly longer than divisions generating viable progeny ( Figure S5E ). Figures 4K-4N ). Hence, both pharmacological treatments reversibly prolong prometaphase of neural progenitors without perturbing ploidy or cleavage plane orientation. We next coupled EdU pulse-chase with the pharmacological paradigm to assess progeny fate at a population level. We pulsed slices with EdU for 30 min to indelibly label a cohort of S-phase progenitors and subsequently applied either DMSO or a mitotic inhibitor for 3 additional hr ( Figures 5A-5C , S6A, and S6B). Prior to drug treatment, the majority of EdU+ cells were PAX6+ RGCs, and 16% were TBR2+ IPs ( Figure S6C ). The 1-hr delay between EdU pulse and drug-treatment corresponds to the time required for EdU+ progenitors to enter mitosis (Takahashi et al., 1995) . Over the 3-hr drug treatment, EdU+ progenitors continued to enter mitosis but were stalled at prometaphase ( Figure 5C ). Both drug treatments led to significantly more mitotically delayed progenitors within the EdU+ population compared with control ( Figure 5B ). At 6-hr post-washout, the localization of EdU+ cells in STLC treated slices was similar to control-treated slices 3 hr earlier, consistent with mitotic delay ( Figure S6B ). By 14-hr post-washout, EdU+ cells were located in the basal VZ and SVZ/CP layers ( Figures 5D-5O and S6B ). Given cell cycle and migration kinetics, this population corresponds to progeny of RGCs and IPs (Takahashi et al., 1995) . Based on published cell-cycle measurements of progenitors (Arai et al., 2011; Takahashi et al., 1995) , we can infer that by 14-hr post-washout, new EdU+ progeny do not have time to complete a second round of mitosis. Thus, a significant proportion of EdU+ cells is direct progeny of mitotically delayed progenitors.
We next assessed apoptosis of EdU+ cells 14-hr postwashout following progenitor mitotic delay. STLC-and nocodazole-treated slices had 21-fold and 8-fold higher respective fractions of apoptotic (CC3+) EdU+ cells compared with control ( Figures 5D-5P ). Apoptotic cells were not detectable until 6-hr post-washout, well after the drug was absent from the media and after progenitors had exited mitosis, arguing against global cytotoxicity ( Figure S6G ). Consistent with the specificity of apoptosis, the majority of CC3+ cells were EdU+ in both STLC and nocodazole treated slices (91% and 85%, respectively) ( Figure S6E ). Altogether these pulse-chase experiments demonstrate that prolonged prometaphase is associated with production of more apoptotic cells, primarily in progeny of mitotically delayed progenitors.
We next assessed neuronal and precursor fates following mitotic delay. We quantified the proportion of EdU-positive cells at 14-hr post-washout as neurons, RGCs, or IPs using TUJ1, PAX6, and TBR2 staining, respectively ( Figures 5D-5O , 5Q, 5S-5X, S6D, and S6F). Strikingly, compared with control, prometaphase delay resulted in 1.5-fold more neurons, evident with either STLC or nocodazole treatment ( Figure 5Q ). Concomitant with the increase of neurons, we observed a significant 25% reduction in IPs (EdU+TBR2+) with either STLC or nocodazole ( Figure 5W ). RGCs (EdU+PAX6+TBR2À) were significantly reduced in STLC, but not in nocodazole ( Figure 5X ). Compared with STLC, nocodazole induces shorter mitotic arrest, which could explain the reduced impact on RGCs. It is possible these overall population changes could be due to preferential progenitor apoptosis. However, apoptosis was evident in equivalent fractions of both EdU+ neurons and EdU+ progenitors, suggesting that it impacts both populations to a similar extent ( Figure 5R ). In sum, these data show that prometaphase delay produces imbalanced numbers of neurons and progenitors.
Prometaphase-Delayed Progenitors Generate Significantly More Neurons, Fewer Progenitors, and Apoptotic Progeny With the observation that mitotic delay induces population level changes, we next used live imaging to directly follow individual progenitor divisions and fate of their progeny. A similar paradigm was used as described in Figure 3A , except E13.5 progenitors were treated with DMSO, STLC, or nocodazole for the first 3 hr of imaging ( Figure 6A ). Importantly, with this paradigm we captured co-cultured progenitors with different mitosis durations, depending on their cell-cycle state at the beginning of the drug treatment. We noted no significant apoptosis of interphase progenitors treated with either STLC or nocodazole (Figures S7A ). This suggests that neither drug impacts overall cell viability, as seen in slice culture experiments. On average, control E13.5 progenitors remained in mitosis about 22 min (Figures 6B). In contrast, mitoses of nocodazole and STLC treated progenitors were on average 54 and 63 min, respectively ( Figure 6B ). 91% of control progenitors completed mitosis within 40 min, whereas only 45% of nocodazole and 52% of STLC-treated progenitors exhibited normal mitosis duration ( Figures 6C and S7B ). These data indicate that nocodazole and STLC treatments can be used to prolong mitosis and evaluate its direct impact on progeny cell fate.
With this paradigm, we examined apoptosis in progeny derived from delayed and non-delayed progenitors. Strikingly, we discovered causal relationships between mitotic delay and subsequent apoptosis for all three conditions: control, STLC-, and nocodazole-treated progenitors. The small fraction of control E13.5 progenitors displaying prolonged mitosis generated significantly more apoptotic progeny, an outcome also manifest by mitotically delayed E14.5 control progenitors ( Figures 6D,  S7H , and S7I). Analysis of the drug-treated progenitors showed a dramatic trend. Delayed progenitors treated with either inhibitor produced significantly more apoptotic progeny than nondelayed counterparts. Approximately 70%-80% of apoptotic divisions gave rise to two dying cells ( Figures 6D and S7C ). Most strikingly, as mitosis duration lengthened in drug-treated progenitors, the probability of producing non-viable progeny significantly increased ( Figure 6E ). For example, STLC-treated progenitors delayed for 60 min produced viable progeny in 80% of their divisions, whereas those delayed beyond 120 min underwent only 14% viable divisions. This relationship between 
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EdU CC3 EdU -Tuj1 CC3 -EdU -Tuj1 CC3 -EdU -Tuj1 Figure 3J ). For all conditions, non-delayed progenitor divisions produced almost 100% viable progeny, consistent with the notion that exposure to inhibitors alone is insufficient to induce cell death ( Figures 6D and 6E) . We then assessed the causal relationship between prolonged mitosis and neuron and progenitor production. We quantified divisions as follows: proliferative P/P (both TUJ1À progenitors), neurogenic P/N (1 TUJ1+), and neurogenic N/N (both TUJ1+) ( Figures 6F and S7D) . A comparison of non-delayed DMSO or drug-treated progenitors showed no significant difference in differentiation or proliferation, indicating that pharmacological treatment alone in cell culture is insufficient to induce differentiation ( Figure 6F ). Strikingly, only those precursors with prolonged mitosis showed altered proliferative and neurogenic divisions, evident to a similar extent with either STLC or nocodazole ( Figures 6F, 6G , and S7D). Moreover, as mitosis duration was prolonged using either drug, there was a concomitant increase in neurogenic divisions, as evident in Magoh +/À -delayed progenitors ( Figure 6G , p < 0.001, both). Although control delayed E13.5 progenitors did not show altered neuron production, control E14.5 progenitors, which have higher neurogenic potency, did show a correlation between prolonged mitosis and increased neurogenic divisions ( Figure S7J ). Finally, we queried whether these phenotypes were evident specifically in E13.5 RGCs ( Figure 6H ). The same causal relationship emerged as in the previous experiment. Prometaphasedelayed RGCs (DsRed-EGFP-) generated significantly more apoptotic progeny compared with control, and underwent significantly more direct neurogenic divisions ( Figures 6I and 6J ). We noted no notable increase in indirect IP-generating divisions ( Figures 6J and S7E-S7G) . Thus, both Magoh +/À and STLCtreated RGCs produce more neurons specifically via asymmetric direct neurogenic divisions. Taken together, these pharmacology results demonstrate that prolonged mitosis alters the balance of progenitor division subtypes, directly leading to increased neuron production, decreased RGC production, and increased apoptotic progeny.
p53 Signaling Distinguishes Mitotic Mechanisms of Differentiation and Apoptosis
These findings indicate that abnormally long mitosis induces both differentiation and cell death in progeny. However, it remains unclear whether these fates are caused by distinct molecular events and how mitotically delayed progenitors direct progeny to die or differentiate. To begin to address these questions, we examined STLC-delayed progenitors to identify candidate pathways linking prolonged mitosis to apoptosis and differentiation. In mitotically delayed immortalized cells, DNA damage response (DDR) can be increased (Ganem and Pellman, 2012) . Indeed, we noted significantly higher DDR in mitotically delayed but not non-delayed telophase progenitors, as assessed by gH2AX staining (Figures 7A-7E ). Interestingly, depletion of Magoh either genetically or in immortalized cells also triggers increased DDR (Silver et al., 2010) . p53 is induced following DDR and is also upregulated following PM-arrest Uetake and Sluder, 2010) , suggesting that it could be an important pathway downstream of damage and mitotic delay. In addition, both p53 signaling and DDR are implicated in apoptosis and differentiation of various stem cell populations, including adult neural stem cells (Gil-Perotin et al., 2006; Inomata et al., 2009; Wang et al., 2012) . We hypothesized that p53 induces both apoptosis and neuronal differentiation following mitotic delay. We first assessed accumulation of p53 in nuclei of STLC-treated slices, as a proxy for pathway activation (Insolera et al., 2014) . By 3 hr following pharmacological treatment, we observed a significant 50-fold increase in p53+EdU+ cells ( Figures 7F-7J , S8A, and S8B). To assess the role of p53 signaling in apoptosis and differentiation, we repeated the EdU pulse-chase experiments described above in a p53 À/À background, using STLC to reversibly delay progenitors in prometaphase ( Figure 7K ). At 14 hr after washout, we observed a complete rescue of apoptosis in STLC treated p53 null slices ( Figures 7L-7P ). If p53 were also required for differentiation, then we expected equivalent rescue of neuron, RGC, and IP number. However, this was not the case. Compared with DMSO-treated p53 À/À slices, significantly more neurons (TUJ1+EdU+) were present in STLC-treated p53 À/À slices ( Figure 7Q ). This indicates aberrant neuronal differentiation occurs in the absence of p53 following mitotic delay. We noted similar fold changes in the fraction of EdU+ neurons and RGCs in both the p53 WT and null backgrounds ( Figure 7R ). In contrast, IP depletion was rescued in the p53 À/À background.
This result could be due to either a role of p53 in IP apoptosis or IP generation. However, if p53 were required for IP generation, one would expect reciprocal rescue of PAX6 and TUJ1 populations, which was not evident. Along with the data in control slices ( Figure 5R ), these findings indicate the following outcomes of mitotic delay: RGCs are depleted due to both apoptosis and fewer RGC producing divisions; IPs are depleted primarily due to apoptosis; and neurons are increased due to more neurogenic divisions. These data are consistent with clonal analysis of drugtreated and Magoh +/À progenitors, in which mitotic delay did not dramatically impact IP generating divisions. The above data indicate that following mitotic delay at the population level, p53 signaling is required for apoptosis, but not for neuronal differentiation. We sought to assess directly the requirement of p53 signaling in these progeny fates using clonal live imaging ( Figure 8A ). Similar to WT, p53-depleted progenitors exhibited mitotic delay following STLC treatment (compare Figures 6B and 6C with Figures 8B and 8C) . Mitotically delayed p53 À/À progenitors produced negligible apoptotic progeny, similar to slice experiments ( Figures 8D, S8C , and S8D). Also reinforcing the slice findings, mitotic-delay induced differentiation was p53 independent. Compared with non-delayed p53 À/À progenitors, delayed p53 À/À progenitors underwent significantly more neurogenic but fewer proliferative divisions ( Figure 8E ). Notably, both p53 null and WT progenitors showed similar fractions of proliferative and neurogenic divisions ( Figure  8E ). Thus, in the absence of apoptosis, there is no significant shift in the balance of proliferative and neurogenic divisions. These data demonstrate that prolonged mitosis of progenitors induces apoptosis in a p53-dependent fashion. In contrast, p53 signaling is not involved in the induction of differentiation following prolonged mitosis (Figures 8F-8I) . Altogether, these analyses reveal that apoptosis and differentiation are mutually exclusive outcomes of mitotic delay.
DISCUSSION
Control of cell-cycle progression has been linked to regulation of cortical development (Arai et al., 2011; Lange et al., 2009; Pilaz et al., 2009; Takahashi et al., 1995) , yet the specific impact of prolonged M phase in specification of neural cell fates has remained enigmatic. Using genetic models and two independent pharmacological approaches, we demonstrate that prolonged mitosis directly alters balanced divisions of RGCs, generating more neurons and apoptotic progeny. Our findings indicate that prolonged mitosis in the Magoh +/À mutant contributes to aberrant neurogenesis and is likely a major contributor to microcephaly of these animals. Taken together, our study has implications for understanding the behavior of neural stem cell populations and for the etiology of microcephaly.
Prometaphase Delay Produces Common Microcephaly Phenotypes
Mitosis defects are proposed to underlie microcephaly and associated neurogenesis phenotypes. Several specific mitotic mechanisms have been invoked to explain this. Altered centrosome number and spindle orientation cause apoptosis, premature differentiation, and mislocalized progenitors (Insolera et al., 2014; Marthiens et al., 2013) . Progenitor depletion and apoptosis can also arise from mitotic catastrophe in which progenitors die prior to division (Chen et al., 2014; Novorol et al., 2013) . Our study highlights prolonged prometaphase as an additional mechanism for influencing cell fate, which can occur independent of aneuploidy, altered cleavage plane orientation, and centrosome integrity. Many mouse microcephaly mutants are reported to increase mitotic index, but few studies have directly analyzed mitotic duration using live imaging. Thus, it will be of interest to examine whether other microcephaly-associated genes also operate via prolonged mitosis. Moreover, we propose prolonged metaphase duration is a valuable parameter to examine in human organoid models of microcephaly (Lancaster et al., 2013) .
Exposing Mechanisms by which Magoh Influences Neurogenesis
We previously demonstrated Magoh haploinsufficient mice exhibit microcephaly due to apoptosis, precocious neurons and reduced IPs; however, the cellular cause of these phenotypes was unclear (Silver et al., 2010) . We can now pinpoint altered balance of neurogenic, proliferative, and viable RGC divisions as a major contributing mechanism. At E12.5, delayed Magoh +/À RGCs directly produce fewer RGCs, more neurons, and more apoptotic progeny. As mitosis duration of Magoh deficient RGCs lengthens, so does the probability of producing fewer progenitors and non-viable cells. The net result is a severe depletion of the progenitor pool, which is predicted to ultimately reduce neurons, as is evident in E18.5 Magoh +/À brains (Silver et al., 2010) . Interestingly, RGCs are not depleted at the population level in microcephalic Magoh +/À cortical columns (Silver et al., 2010) , suggesting that Magoh regulation of RGCs is especially relevant in the tangential dimension. Magoh is part of the exon junction RNA binding complex, components of which are associated with human neurodevelopmental phenotypes, including microcephaly (Mao et al., 2015; Pilaz and Silver, 2015) . Our findings may have broad relevance for understanding roles of this complex in human brain development.
It (Silver et al., 2010) , and it is plausible that mitotic delay is a consequence of earlier damage, which could also influence progeny fate. It is also possible that mitotically delayed Magoh +/À progenitors express a slightly different repertoire of Magoh-dependent pro-differentiation determinants, such as Ngn2, Tbr2, and LIS1 protein (Silver et al., 2010) . In considering these possibilities, it will be of interest to understand why only a subpopulation of RGCs are affected by Magoh haploinsufficiency. One potential explanation is stochastic Magoh levels but another intriguing idea is that delayed progenitors are fundamentally distinct. Indeed, heterogeneous populations of RGCs have been reported (Franco and Mü ller, 2013; Tyler et al., 2015) . Defining transcriptomic and proteomic differences in Magoh +/À progenitors with normal and prolonged mitoses will help to address these fascinating questions. How does Magoh influence mitosis? The most striking defect in Magoh-depleted mitotic cells was in microtubule organization, leading us to posit Magoh regulates mitotic progression by controlling spindle dynamics and anaphase onset. Consistent with this notion, mago nashi, the Magoh ortholog, is required for microtubule dynamics in Drosophila oocytes (Micklem et al., 1997) . Our data indicate that Magoh can influence microtubules indirectly, by modulating expression of key microtubule/mitosis regulatory proteins. However, Magoh may also directly influence microtubule organization; it localizes to the mitotic spindle (Ishigaki et al., 2014) , was identified in proteomic studies as a mitotic spindle component (Bonner et al., 2011; Sauer et al., 2005) , and physically associates with the microtubule-associated protein MAP1B (Tretyakova et al., 2005) . It will be interesting to assess whether Magoh's RNA binding function is necessary for microtubule regulation and if so to identify its RNA cargos specifically at M phase. Future studies aimed at understanding how Magoh influences microtubules will help illuminate the root causes of the mitosis delay. (E) Proportion of P/P (white), P/N (gray), and N/N (black) divisions of delayed and non-delayed progenitors from indicated treatments.
(F-I) Models depicting how prolonged neural progenitor mitosis influences the survival and fate of direct progeny. RGCs with prolonged mitosis directly produce neurons at the expense of new RGCs in a p53-independent manner (F and H). With excessively longer mitosis, RGCs are more likely to generate apoptotic progeny via p53-dependent mechanisms (F and I). ns, not significant, *p < 0.05, ***p < 0.001.
Potential Mechanisms Linking Prometaphase to Altered Cell Fate
We show mitotically delayed progenitors have increased propensity for generating apoptotic progeny and differentiated neurons. Our data indicate that as mitosis lengthens, the probability for producing apoptotic progeny increases. In Magoh +/À , STLC and nocodazole treated progenitors, extremely long mitoses generate primarily apoptotic fates, whereas increased neurogenic divisions are first evident in shorter delays. We speculate that neural progenitors have an internal clock, which measures mitosis duration. This model has been invoked to explain why mitotically delayed immortalized cells produce G1-arrested progeny (Uetake and Sluder, 2010) . Progenitors with longer mitoses may be deemed damaged or problematic, forcing their progeny to die or exit the cell cycle. In support of this model, our genetic and pharmacology experiments indicate that delayed cells generate aberrant neurons via direct neurogenic rather than indirect IP-generating divisions. Thus, mitotic delay causes progenitors to preferentially produce post-mitotic or apoptotic progeny rather than generating new progenitors.
How does longer mitosis induce cell fate changes in progeny? In this study, we examined several potential mechanisms. In drug-treated progenitors, neither increased aneuploidy nor misoriented spindles explain observed cell fate changes. In contrast, mitotically delayed progenitors showed increased gH2AX staining prior to completion of mitosis. Subsequent progeny exhibited P53 activation, which induced apoptosis. As p53 loss rescued apoptosis but not differentiation, it is intriguing to consider if other DDR-dependent signaling pathways promote differentiation. Notably, DDR can trigger differentiation of stem cell populations, including adult neural stem cells, making it an interesting avenue for future studies (Gil-Perotin et al., 2006; Inomata et al., 2009; Sherman et al., 2011; Wang et al., 2012) . Identifying the molecular mechanisms driving delay-induced differentiation is a high priority for future studies.
Mitotic Regulation and the Developing Brain
Our study indicates prolonged mitosis can alter cell fates in a pathogenic state, but it is interesting to consider its potential role during normal development. Haydar et al. (2003) showed that over the course of corticogenesis as more neurons are being produced, neural progenitor metaphase duration increases. We observed that prolonged mitosis could impact normal development as evidenced by significantly more apoptotic progeny from delayed control progenitors at E13.5 and E14.5. E14.5 control progenitors delayed in mitosis also underwent more neurogenic divisions. These outcomes were not evident at E12.5, perhaps because there are fewer delayed progenitors at this age. Thus, the relatively subtle relationships between duration and cell fate may be more pronounced at older stages when progenitor divisions are longer and more neurogenic and/ or when measured with less pro-proliferative culture conditions. Studies of older stages are also particularly relevant for assessing the role of mitotic duration in different progenitor populations and in the generation of distinct neuronal and glial subtypes. Our findings provide rationale for future detailed analysis of the role of mitosis duration in influencing normal brain development.
Beyond normal mouse development, cell-cycle differences are one of the most distinguishing traits differentiating the brains of mice, non-human primates, and humans (Geschwind and Rakic, 2013) . Such differences are postulated to influence brain size, shape, and neuronal number. Thus, in future studies, we should consider not only the potential role that prolonged mitotic duration plays in the etiology of microcephaly, but also in defining species-specific differences in brain development.
EXPERIMENTAL PROCEDURES Statistical Analyses and Quantitation
See Table S1 for details regarding statistical analysis. All graphs depict average and SD values, and error bars denote biological variation. When possible, all analyses were performed by more than one person, blind to genotype. For this manuscript, RGCs were denoted either by their division at the apical surface, expression of PAX6, or absence of TBR2 expression at E12.5.
Live Analyses
For clonal analysis, progenitors were cultured as previously described (Shen et al., 2002) . For brain-slice imaging, analysis was performed as previously described (Pilaz and Silver, 2014) . Because pharmacology can potentially have off-target effects, in our experimental paradigm, we rule out impacts of nocodazole and STLC on interphase viability, cleavage plane orientation, and exclude aneuploidy as an outcome of STLC. 
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